Skip to main content
. 2017 Jun 9;18(6):1240. doi: 10.3390/ijms18061240
mCRC Metastatic colorectal cancer
CT Chemotherapy
B Bevacizumab
VEGF Vascular endothelial growth factor
eNOS Endothelial nitric oxide synthase
COX2 Cyclooxygenase-2
EPHB4 Ephrin type-B receptor 4
HIF-1 Hypoxia-inducible factor 1
LDH Lactate dehydrogenase
hs-CRP High-sensitivity C-reactive protein
NLR Neutrophil-lymphocyte ratio
PLR Platelet-lymphocyte ratio
SII Systemic immune-inflammation index
PFS Progression-free survival
OS Overall survival